Goren MP - Search Results

1

Ifosfamide in pediatric malignant solid tumors.

Pratt CB, Douglass EC, Etcubanas EL, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA. Pratt CB, et al. Among authors: goren mp. Cancer Chemother Pharmacol. 1989;24 Suppl 1:S24-7. doi: 10.1007/BF00253234. Cancer Chemother Pharmacol. 1989. PMID: 2503257

2

False-positive ketone tests: a bedside measure of urinary mesna.

Goren MP, Pratt CB. Goren MP, et al. Cancer Chemother Pharmacol. 1990;25(5):371-2. doi: 10.1007/BF00686240. Cancer Chemother Pharmacol. 1990. PMID: 2106398

3

Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors.

Pratt CB, Goren MP, Meyer WH, Singh B, Dodge RK. Pratt CB, et al. Among authors: goren mp. J Clin Oncol. 1990 Aug;8(8):1399-401. doi: 10.1200/JCO.1990.8.8.1399. J Clin Oncol. 1990. PMID: 2380760

4

Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.

Pratt CB, Douglass EC, Etcubanas E, Goren MP, Green AA, Hayes FA, Horowitz ME, Meyer WH, Thompson EI, Wilimas JA. Pratt CB, et al. Among authors: goren mp. Semin Oncol. 1989 Feb;16(1 Suppl 3):51-5. Semin Oncol. 1989. PMID: 2495567

5

Mesna excretion and ifosfamide nephrotoxicity in children.

Goren MP, Pratt CB, Meyer WH, Wright RK, Dodge RK, Viar MJ. Goren MP, et al. Cancer Res. 1989 Dec 15;49(24 Pt 1):7153-7. Cancer Res. 1989. PMID: 2510931

6

Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.

Goren MP, Pratt CB, Viar MJ. Goren MP, et al. Cancer Chemother Pharmacol. 1989;25(1):70-2. doi: 10.1007/BF00694342. Cancer Chemother Pharmacol. 1989. PMID: 2574077

7

Cumulative renal tubular damage associated with cisplatin nephrotoxicity.

Goren MP, Wright RK, Horowitz ME. Goren MP, et al. Cancer Chemother Pharmacol. 1986;18(1):69-73. doi: 10.1007/BF00253068. Cancer Chemother Pharmacol. 1986. PMID: 2875808

8

Enhancement of methotrexate nephrotoxicity after cisplatin therapy.

Goren MP, Wright RK, Horowitz ME, Meyer WH. Goren MP, et al. Cancer. 1986 Dec 15;58(12):2617-21. doi: 10.1002/1097-0142(19861215)58:12<2617::aid-cncr2820581211>3.0.co;2-b. Cancer. 1986. PMID: 2877729

9

Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.

Goren MP, Wright RK, Horowitz ME, Pratt CB. Goren MP, et al. Cancer Treat Rep. 1987 Feb;71(2):127-30. Cancer Treat Rep. 1987. PMID: 2879626

10

Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.

Goren MP, Forastiere AA, Wright RK, Horowitz ME, Dodge RK, Kamen BA, Viar MJ, Pratt CB. Goren MP, et al. Cancer Chemother Pharmacol. 1987;19(1):57-60. doi: 10.1007/BF00296257. Cancer Chemother Pharmacol. 1987. PMID: 2880677 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters